Nkarta to Present Initial NKX019 Autoimmune Data at ACR 2026
SOUTH SAN FRANCISCO, California — September 8, 2026 Nkarta, Inc. announced that three scientific presentations featuring NKX019 have been...
B-cell depletion
Advertisement
Artiva Biotherapeutics Advances AlloNK Toward Phase 3 in RA
SAN DIEGO, California — September 8, 2026 Artiva Biotherapeutics, Inc. announced planned clinical data disclosures and development milestones for...
TG Therapeutics Launches Phase 2 BRIUMVI Trial
NEW YORK, July 6, 2026 TG Therapeutics, Inc. announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI®...
Artiva Biotherapeutics Showcases AlloNK Data at EULAR 2026
SAN DIEGO, California, May 19, 2026 Artiva Biotherapeutics announced multiple data presentations at the upcoming EULAR 2026 Congress highlighting...
Kyverna Therapeutics Reports Breakthrough Phase 2 Results for KYV-101 in Myasthenia Gravis
Emeryville, California, October 29, 2025 — Kyverna Therapeutics Inc. (Nasdaq: KYTX) announced positive interim Phase 2 data from the...
Advertisement
